TY - JOUR
T1 - Exacerbation of invasive candida albicans infection by commensal bacteria or a glycolipid through IFN- Produced in part by iNKT cells
AU - Tarumoto, Norihito
AU - Kinjo, Yuki
AU - Kitano, Naoki
AU - Sasai, Daisuke
AU - Ueno, Keigo
AU - Okawara, Akiko
AU - Izawa, Yuina
AU - Shinozaki, Minoru
AU - Watarai, Hiroshi
AU - Taniguchi, Masaru
AU - Takeyama, Haruko
AU - Maesaki, Shigefumi
AU - Shibuya, Kazutoshi
AU - Miyazaki, Yoshitsugu
N1 - Funding Information:
Financial support. This work was supported by grants from the Ministry of Health, Labor and Welfare of Japan (H23-shinkou-ippan-018 and H22-shinkou-ippan-008 to Y. M. and K. S., H23-shinkou-ippan-007 and H24-shinkou-ippan-013 to Y. M.); the Japan Society for the Promotion of Science and the Japanese Ministry of Education, Culture, Sports, Science and Technology (Y. K.); and the Takeda Science Foundation (Y. K.).
PY - 2014/3
Y1 - 2014/3
N2 - Background. The commensal yeast Candida albicans is a major cause of invasive fungal infections. Despite treatment with antifungal agents, the mortality rate attributed to these types of infection is high. Although numerous cases have been reported regarding a poor outcome for patients with bacterial and C. albicans coinfection, the mechanisms by which the coinfecting bacteria exacerbate the C. albicans infection remain elusive.Methods and Results We evaluated how glycolipid-mediated activation of invariant natural killer T (iNKT) cells affects the clearance of C. albicans. Surprisingly, C. albicans-infected, glycolipid-treated mice exhibited significantly lower survival rates, increased fungal burden, and higher interleukin (IL)-6 production in the kidneys compared with control mice. Glycolipid-induced exacerbation of C. albicans infection was not observed in interferon-gamma knockout (IFN-KO) mice. In the C. albicans-infected, glycolipid-treated mice, the number of neutrophils in the blood and bone marrow dramatically decreased in an IFN--dependent manner. Furthermore, mice that were coinfected with C. albicans and nonfermentative gram-negative commensal bacteria exhibited increased fungal burden and inflammatory cytokine production in the kidneys that were dependent on IFN- and iNKT cells.Conclusions. Our results indicate that coinfecting commensal bacteria exacerbate C. albicans infection through IFN- produced, in part, by iNKT cells.
AB - Background. The commensal yeast Candida albicans is a major cause of invasive fungal infections. Despite treatment with antifungal agents, the mortality rate attributed to these types of infection is high. Although numerous cases have been reported regarding a poor outcome for patients with bacterial and C. albicans coinfection, the mechanisms by which the coinfecting bacteria exacerbate the C. albicans infection remain elusive.Methods and Results We evaluated how glycolipid-mediated activation of invariant natural killer T (iNKT) cells affects the clearance of C. albicans. Surprisingly, C. albicans-infected, glycolipid-treated mice exhibited significantly lower survival rates, increased fungal burden, and higher interleukin (IL)-6 production in the kidneys compared with control mice. Glycolipid-induced exacerbation of C. albicans infection was not observed in interferon-gamma knockout (IFN-KO) mice. In the C. albicans-infected, glycolipid-treated mice, the number of neutrophils in the blood and bone marrow dramatically decreased in an IFN--dependent manner. Furthermore, mice that were coinfected with C. albicans and nonfermentative gram-negative commensal bacteria exhibited increased fungal burden and inflammatory cytokine production in the kidneys that were dependent on IFN- and iNKT cells.Conclusions. Our results indicate that coinfecting commensal bacteria exacerbate C. albicans infection through IFN- produced, in part, by iNKT cells.
KW - Candida albicans
KW - commensal bacteria
KW - glycolipid
KW - iNKT cell
KW - nonfermentative gram-negative bacteria
UR - http://www.scopus.com/inward/record.url?scp=84894249542&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84894249542&partnerID=8YFLogxK
U2 - 10.1093/infdis/jit534
DO - 10.1093/infdis/jit534
M3 - Article
C2 - 24096333
AN - SCOPUS:84894249542
SN - 0022-1899
VL - 209
SP - 799
EP - 810
JO - Journal of Infectious Diseases
JF - Journal of Infectious Diseases
IS - 5
ER -